K161863 is an FDA 510(k) clearance for the ReUnion Reversible Fracture System (RFX), ReUnion Reverse Shoulder Arthroplasty (RSA), ReUnion Total Shoulder Arthroplasty (TSA). This device is classified as a Prosthesis, Shoulder, Semi-constrained, Metal/polymer Cemented (Class II - Special Controls, product code KWS).
Submitted by Stryker GmbH (Selzach, CH). The FDA issued a Cleared decision on November 23, 2016, 140 days after receiving the submission on July 6, 2016.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3660.